Tags

Type your tag names separated by a space and hit enter

Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.
Diagn Microbiol Infect Dis. 2020 Sep; 98(1):115094.DM

Abstract

Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. The current classification of coronaviruses recognizes 39 species in 27 subgenera that belong to the family Coronaviridae. From those, at least 7 coronaviruses are known to cause respiratory infections in humans. Four of these viruses can cause common cold-like symptoms. Those that infect animals can evolve and become infectious to humans. Three recent examples of these viral jumps include SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the most recently discovered coronavirus disease during 2019 (COVID-19). COVID-19, a respiratory disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. The rapid spread of the disease has taken the scientific and medical community by surprise. Latest figures from 20 May 2020 show more than 5 million people had been infected with the virus, causing more than 330,000 deaths in over 210 countries worldwide. The large amount of information received daily relating to COVID-19 is so abundant and dynamic that medical staff, health authorities, academics and the media are not able to keep up with this new pandemic. In order to offer a clear insight of the extensive literature available, we have conducted a comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19).

Authors+Show Affiliations

One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: e.ortizprado@gmail.com.One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: ksimbanarivera@gmail.com.One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: lsgomezbarreno@gmail.com.Hospital Baca Ortiz, Pediatric and Cardiology Department, Quito, Ecuador. Electronic address: drrubio24@yahoo.com.Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador. Electronic address: linda.guaman@ute.edu.ec.Grupo de Investigación en Biotecnología Aplicada a Biomedicina (BIOMED), Universidad de la Americas, Quito, Ecuador. Electronic address: nikolaos.kyriakidis@udla.edu.ec.One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: claire.muslin@udla.edu.ec.Faculty of Medicine, Pontificia Universidad Católica del Ecuador, Quito, Ecuador. Electronic address: mdanamagomez84@gmail.com.One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: carlos.barba.ostria@udla.edu.ec.Intensive Care Unit, Hospital Quito Sur IESS, Quito, Ecuador. Electronic address: domecevallos.92@gmail.com.One Health Research Group, Faculty of Medicine, Universidad de Las Americas (UDLA), Quito, Ecuador. Electronic address: hmssanmiguel@icloud.com.Intensive Care Unit, Hospital SOLCA Quito, Quito, Ecuador. Electronic address: luisunigarro3@gmail.com.Grupo de Biodiversidad Medio Ambiente y Salud (BIOMAS), Universidad de Las Américas, Quito, Ecuador; Intelligent and Interactive Systems Lab (SI2 Lab) Universidad de Las Américas (UDLA), Quito, Ecuador. Electronic address: rasa.zalakeviciute@udla.edu.ec.University of Southampton, Department of Public Health, Southampton, United Kingdome. Electronic address: naomigadian@hotmail.com.Centro de Investigación Genética y Genómica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador; Red Latinoamericana de Implementación y Validación de Guías Clínicas Farmacogenómicas (RELIVAF-CYTED), Quito, Ecuador. Electronic address: aalc84@gmail.com.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32623267

Citation

Ortiz-Prado, Esteban, et al. "Clinical, Molecular, and Epidemiological Characterization of the SARS-CoV-2 Virus and the Coronavirus Disease 2019 (COVID-19), a Comprehensive Literature Review." Diagnostic Microbiology and Infectious Disease, vol. 98, no. 1, 2020, p. 115094.
Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98(1):115094.
Ortiz-Prado, E., Simbaña-Rivera, K., Gómez-Barreno, L., Rubio-Neira, M., Guaman, L. P., Kyriakidis, N. C., Muslin, C., Jaramillo, A. M. G., Barba-Ostria, C., Cevallos-Robalino, D., Sanches-SanMiguel, H., Unigarro, L., Zalakeviciute, R., Gadian, N., & López-Cortés, A. (2020). Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagnostic Microbiology and Infectious Disease, 98(1), 115094. https://doi.org/10.1016/j.diagmicrobio.2020.115094
Ortiz-Prado E, et al. Clinical, Molecular, and Epidemiological Characterization of the SARS-CoV-2 Virus and the Coronavirus Disease 2019 (COVID-19), a Comprehensive Literature Review. Diagn Microbiol Infect Dis. 2020;98(1):115094. PubMed PMID: 32623267.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. AU - Ortiz-Prado,Esteban, AU - Simbaña-Rivera,Katherine, AU - Gómez-Barreno,Lenin, AU - Rubio-Neira,Mario, AU - Guaman,Linda P, AU - Kyriakidis,Nikolaos C, AU - Muslin,Claire, AU - Jaramillo,Ana María Gómez, AU - Barba-Ostria,Carlos, AU - Cevallos-Robalino,Doménica, AU - Sanches-SanMiguel,Hugo, AU - Unigarro,Luis, AU - Zalakeviciute,Rasa, AU - Gadian,Naomi, AU - López-Cortés,Andrés, Y1 - 2020/05/30/ PY - 2020/04/14/received PY - 2020/05/21/revised PY - 2020/05/22/accepted PY - 2020/7/6/pubmed PY - 2020/8/18/medline PY - 2020/7/6/entrez KW - COVID-19 KW - Coronavirus KW - Pandemic KW - Review KW - SARS-CoV-2 SP - 115094 EP - 115094 JF - Diagnostic microbiology and infectious disease JO - Diagn Microbiol Infect Dis VL - 98 IS - 1 N2 - Coronaviruses are an extensive family of viruses that can cause disease in both animals and humans. The current classification of coronaviruses recognizes 39 species in 27 subgenera that belong to the family Coronaviridae. From those, at least 7 coronaviruses are known to cause respiratory infections in humans. Four of these viruses can cause common cold-like symptoms. Those that infect animals can evolve and become infectious to humans. Three recent examples of these viral jumps include SARS CoV, MERS-CoV and SARS CoV-2 virus. They are responsible for causing severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and the most recently discovered coronavirus disease during 2019 (COVID-19). COVID-19, a respiratory disease caused by the SARS-CoV-2 virus, was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. The rapid spread of the disease has taken the scientific and medical community by surprise. Latest figures from 20 May 2020 show more than 5 million people had been infected with the virus, causing more than 330,000 deaths in over 210 countries worldwide. The large amount of information received daily relating to COVID-19 is so abundant and dynamic that medical staff, health authorities, academics and the media are not able to keep up with this new pandemic. In order to offer a clear insight of the extensive literature available, we have conducted a comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19). SN - 1879-0070 UR - https://www.unboundmedicine.com/medline/citation/32623267/Clinical_molecular_and_epidemiological_characterization_of_the_SARS_CoV_2_virus_and_the_Coronavirus_Disease_2019__COVID_19__a_comprehensive_literature_review_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0732-8893(20)30471-5 DB - PRIME DP - Unbound Medicine ER -